NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-148-2011-0-CZ-21 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CZ EP 12710856.1 Issued
NCI E-148-2011-0-BE-19 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer BE EP 12710856.1 Issued
NCI E-148-2011-0-AT-18 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AT EP 12710856.1 Issued
NCI E-148-2011-0-FR-24 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer FR EP 12710856.1 Issued
NCI E-148-2011-0-DE-22 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer DE EP 12710856.1 Issued
NCI E-148-2011-0-IE-27 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IE EP 12710856.1 Issued
NCI E-148-2011-0-GR-26 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer GR EP 12710856.1 Issued
NCI E-148-2011-0-IT-28 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IT EP 12710856.1 Issued
NCI E-148-2011-0-PL-31 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PL EP 12710856.1 Issued
NCI E-148-2011-0-NO-30 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer NO EP 12710856.1 Issued
NCI E-148-2011-0-SI-34 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SI EP 12710856.1 Issued
NCI E-148-2011-0-NL-29 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer NL EP 12710856.1 Issued
NCI E-148-2011-0-PT-32 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PT EP 12710856.1 Issued
NCI E-148-2011-0-SK-35 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SK EP 12710856.1 Issued
NIA E-084-2011-0-EP-05 Compositions and Methods for Enhancing the Pluripotency of Stem Cells EP National Stage 12760251.4 Issued
NIA E-084-2011-0-AU-03 Compositions and Methods for Enhancing the Pluripotency of Stem Cells AU National Stage 2012230894 Issued
NCI E-148-2011-0-AU-03 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AU National Stage 2012240562 Issued
NCI E-014-2000-0-US-05 Methods of Use of Fragments of Secreted Frizzled Related Protein, sFRP US DIV 13/426,520 8735355 Expired PDF
NCI E-148-2011-0-PCT-02 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PCT PCT PCT/US12/29861 Abandoned
NIA E-084-2011-0-PCT-02 Compositions and Methods for Enhancing the Pluripotency of Stem Cells PCT PCT PCT/US2012/030005 Expired
NCI E-205-2009-0-JP-05 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP National Stage 2012-532100 Abandoned
NIAID E-023-2003-0-AU-11 MVA Expressing Modified HIV Envelope, GAG, and POL Genes AU DIV 2012201689 Abandoned
NINDS E-025-2013-0-US-01 OASIS: Automated Brain Lesion Detection Using Cross Sectional Multimodality Magnetic Resonance Imaging US 61/613,569 Abandoned
NIDA E-128-2006-0-CA-04 4-Phenylpiperazine Derivatives With Functionalized Linkers as Dopamine D3 Receptor Selective Ligands and Methods Of Use CA National Stage 2690789 Issued
NCI E-114-2011-0-PCT-02 Methods Of Growing Tumor Infiltrating Lymphocytes In Gas-Permeable Containers PCT PCT PCT/US2012/029744 Expired
NCI E-114-2011-0-US-03 Methods Of Growing Tumor Infiltrating Lymphocytes In Gas-Permeable Containers US ORD 13/424,646 Abandoned
NIAID E-051-2012-1-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US 61/613,431 Abandoned
NCI E-056-2011-0-EP-43 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS EP DIV 17154014.9 Issued
NCI E-056-2011-0-BR-05 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer BR National Stage BR112013023456-3 Issued
NCI E-056-2011-0-IN-10 YEAST BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS IN National Stage 8692/DELNP/2013 Issued
NCI E-056-2011-0-IL-09 YEAST-BRACHYURY ANTIGEN IMMUNOTHERAPEUTIC COMPOUNDS IL National Stage 228421 Issued
NIAID E-300-2009-5-CA-03 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE CA National Stage 2774636 Issued
NCI E-056-2011-0-CN-07 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer CN National Stage 201280023412.6 Issued
NCI E-056-2011-0-HK-17 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS HK National Stage 14105080.4 Issued
NCI E-056-2011-0-MX-13 Yeast-Based Immunotherapy for Chordoma MX National Stage MX/a/2013/010475 Issued
NCI E-056-2011-0-RU-16 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer RU National Stage 2013146324 Issued
NCI E-056-2011-0-NO-36 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS NO EP 12757534.8 Issued
NCI E-056-2011-0-PT-38 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS PT EP 12757534.8 Issued
NCI E-056-2011-0-PL-37 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS PL EP 12757534.8 Issued
NCI E-056-2011-0-NL-35 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS NL EP 12757534.8 Issued
NCI E-056-2011-0-CZ-24 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CZ EP 12757534.8 Issued
NCI E-056-2011-0-LU-34 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS LU EP 12757534.8 Issued
NCI E-056-2011-0-TR-40 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS TR EP 12757534.8 Issued
NCI E-056-2011-0-CH-23 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CH EP 12757534.8 Issued
NCI E-056-2011-0-ES-27 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS ES EP 12757534.8 Issued
NCI E-056-2011-0-SE-39 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS SE EP 12757534.8 Issued
NCI E-056-2011-0-GB-30 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS GB EP 12757534.8 Issued
NCI E-056-2011-0-IE-32 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS IE EP 12757534.8 Issued
NCI E-056-2011-0-HU-31 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS HU EP 12757534.8 Issued
NCI E-056-2011-0-IT-33 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS IT EP 12757534.8 Issued